Brief: YiChang HEC ChangJiang Pharmaceutical Posts H1 Net Income RMB684.7 Million
30/08/2024 13:37
Aug 30 (Reuters) - YiChang HEC ChangJiang Pharmaceutical H1 gross profit RMB 1,949.2 million. * H1 basic EPS RMB 0.78 * H1 net income RMB 684.7 million * H1 pretax profit RMB 813.5 million
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million